Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

DoctorAdam vs Voxy

DoctorAdam
Graded #54

Higher grade

vs+13.500000000000007
Voxy
Graded #272

Lower grade

The verdict

DoctorAdam takes it — 75.9/100 to 62.4/100.

DoctorAdam grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. DoctorAdam is a Shopify-based telehealth platform offering compounded semaglutide and tirzepatide in both injection and oral tablet forms, with flat all-in monthly pricing covering physician evaluation,…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueDoctorAdam +27
78
51
Dose & formulationDoctorAdam +24
88
64
Clinical oversightDoctorAdam +3
85
82
Labs & monitoringVoxy +10
53
63
FulfillmentDoctorAdam +1
79
78
Contract termsDoctorAdam +35
55
20
DoctorAdam · left barVoxy · right bar

The numbers

MetricDoctorAdamVoxy
WeighScore75.9/10062.4/100
GradeCC
Scorecard rank#54#272
Semaglutide$129/mo (starting dose, compounded)$179/mo (compounded)
Tirzepatide$229/mo (starting dose, compounded)$299/mo (compounded)
Coverage44 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
DoctorAdam

Graded #54 · C

Strengths

  • Offers both injection and oral tablet forms of compounded semaglutide and tirzepatide
  • Flat all-in pricing — physician evaluation, medication, and free shipping included
  • Named pharmacy partners: Olympia Pharmaceuticals (Orlando, FL) and Carie Boyd Pharmaceuticals (Irving, TX)
  • LegitScript certified with 4.8/5 Trustpilot score from 5,400+ reviews and 100K+ patients
  • No hidden fees, no required recurring commitment, full refund if not prescribed

Where it loses points

  • Compounded medications are not FDA-approved individual drugs
  • No labs or dedicated coaching disclosed on public pages
  • Only 44 states served — AK, MA, MS, NJ, RI, and VT excluded despite homepage '50 states' claim
  • Dose-tier pricing not published; only starting prices visible without quiz
  • Shopify-based store rather than a dedicated health platform
Voxy

Graded #272 · C

Strengths

  • Names both its compounding pharmacy (VialsRX, Houston TX) and its prescribing medical group (Arora Health & Aesthetics) — most name neither
  • Publishes the full price ladder for both drugs across 1-, 3-, 6- and 12-month terms before you start the assessment
  • One price covers the provider visit, medication, injection supplies, shipping and monthly check-ins — no separate membership fee
  • True month-to-month option at $179 semaglutide / $299 tirzepatide with no commitment required
  • Free assessment with no charge to see if you qualify, and no labs required to start

Where it loses points

  • No terms of service anywhere on the site — /terms, /terms-of-service and /terms-of-use all return 404
  • No refund policy published; the only stated commitment language is 'cancel anytime'
  • Advertised 'Starting at $129/mo' is the 12-month prepay rate — month-to-month is $179 semaglutide and $299 tirzepatide
  • No public list of states served; availability depends on where affiliated providers are licensed
  • The prescribing nurse practitioner is not named — 'provider details available during your consultation'

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard